Ayurvedic Dravyaguna (Pharmacological) Correlates with Biological Plausibility for antidiabetic activity of Eujenia jambolana Linn

Please use this identifier to cite or link to this item: http://tdudspace.texicon.in:8080/jspui/handle/123456789/674

Full metadata record

DC Field	Value	Language
dc.contributor.author	Nabar, Nutan Sham	-
dc.contributor.author	Vaidya, Rama Ashok	-
dc.contributor.author	Chethala N, Vishnuprasad	-
dc.contributor.author	Vaidya, Ashok DB	-
dc.date.accessioned	2025-04-11T11:08:12Z	-
dc.date.available	2025-04-11T11:08:12Z	-
dc.date.issued	2020-02	-
dc.identifier.uri	http://tdudspace.texicon.in:8080/jspui/handle/123456789/674	-
dc.description.abstract	Eujenia jambolana Linn (Jambu / Black plum; EjL) was found to be a frequently used medicinal plant in our earlier study of Marketed Ayurvedic Antidiabetic Formulations. Ayurvedic dravyaguna rationale and Biological Plausibility (BP) of EjL for anti-diabetic activity are currently reviewed in view of developing a new drug candidate for type 2 diabetes mellitus using Reverse Pharmacology. Classical and emerging Ayurvedic literature as well as modern pharmacological literature of EjL were reviewed here for Ayurvedic properties and biological plausibility foranti-diabetic potentials.	en_US
dc.language.iso	en	en_US
dc.publisher	The Indian Practitioner	en_US
dc.subject	Indian medicinal plants	en_US
dc.subject	Dravyaguna rationale	en_US
dc.subject	Biological plausibility	en_US
dc.subject	diabetes	en_US
dc.subject	Ayurvedic Pharmacoepidemiology	en_US
dc.subject	Eugenia jambolana	en_US
dc.subject	Jambu	en_US
dc.title	Ayurvedic Dravyaguna (Pharmacological) Correlates with Biological Plausibility for antidiabetic activity of Eujenia jambolana Linn	en_US
dc.type	Article	en_US
Appears in Collections:	Researcher/Student Publications

Files in This Item:

File	Description	Size	Format
AyurvedicDravyagunaandBiologicalPlausibility.pdf		480.88 kB	Adobe PDF	View/Open